Biophar Group

Laboratoires Biophar is a leading Moroccan pharmaceutical company and a major subsidiary of the Sothema Group. The company specializes in the manufacturing and distribution of a wide range of pharmaceutical products, including generics, biologics, and biosimilars, serving markets across Africa and the Middle East. Biophar is particularly recognized for its large-scale production of insulin and its strategic role in manufacturing the Sinopharm COVID-19 vaccine in Morocco. With advanced manufacturing facilities, the company partners with global pharmaceutical giants to provide high-quality healthcare solutions across various therapeutic areas such as oncology, endocrinology, and infectious diseases.